R. Ramelmeier
Chief Tech/Sci/R&D Officer chez ADVERUM BIOTECHNOLOGIES, INC.
Fortune : 59 014 $ au 31/03/2024
Postes actifs de R. Ramelmeier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 21/08/2023 | - |
Historique de carrière de R. Ramelmeier
Anciens postes connus de R. Ramelmeier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | 10/07/2023 |
| Corporate Officer/Principal | 01/01/2018 | - | |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2014 | 01/01/2017 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2006 | 01/01/2014 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | 01/01/2001 | 01/01/2005 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Formation de R. Ramelmeier
| The Johns Hopkins University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- R. Ramelmeier
- Expérience
